-
201
CD19 -targeted CAR T therapy treating hematologic malignancies: hidden danger is the next neighbor to security?
Published 2025-03-01Subjects: Get full text
Article -
202
In vitro maintaining of CD4+ central and effector memory cells in normal and inflammatory conditions
Published 2020-12-01Subjects: Get full text
Article -
203
-
204
-
205
eEF-2K Deficiency Boosts the Virus-Specific Effector CD8<sup>+</sup> T Cell Responses During Viral Infection
Published 2024-12-01Subjects: Get full text
Article -
206
Multicellular Cancer-Stroma Spheres (CSS) for In Vitro Assessment of CAR-T Cell-Associated Toxicity
Published 2024-11-01Subjects: Get full text
Article -
207
A <i>Puccinia striiformis</i> f. sp. <i>tritici</i> Effector with DPBB Domain Suppresses Wheat Defense
Published 2025-02-01Subjects: Get full text
Article -
208
Management strategies for CAR-T cell therapy-related toxicities: results from a survey in Greece
Published 2025-05-01Subjects: Get full text
Article -
209
Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study
Published 2024-12-01Subjects: Get full text
Article -
210
Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report
Published 2025-04-01Subjects: Get full text
Article -
211
Prospects for combining the methods of haploid biotechnology and genome editing to improve spiked grains of the <i>Triticeae</i> family (review)
Published 2024-07-01Subjects: “…talen (transcription activator-like effector nucleases)…”
Get full text
Article